These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33067626)

  • 1. The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.
    Monaghan RM; Page DJ; Ostergaard P; Keavney BD
    Cardiovasc Res; 2021 Jul; 117(8):1877-1890. PubMed ID: 33067626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms.
    Monaghan RM; Naylor RW; Flatman D; Kasher PR; Williams SG; Keavney BD
    Cardiovasc Res; 2024 Sep; 120(10):1164-1176. PubMed ID: 38713105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.
    Connell FC; Ostergaard P; Carver C; Brice G; Williams N; Mansour S; Mortimer PS; Jeffery S;
    Hum Genet; 2009 Jan; 124(6):625-31. PubMed ID: 19002718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.
    Ghalamkarpour A; Holnthoner W; Saharinen P; Boon LM; Mulliken JB; Alitalo K; Vikkula M
    J Med Genet; 2009 Jun; 46(6):399-404. PubMed ID: 19289394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic dysfunction, not aplasia, underlies Milroy disease.
    Mellor RH; Hubert CE; Stanton AW; Tate N; Akhras V; Smith A; Burnand KG; Jeffery S; Mäkinen T; Levick JR; Mortimer PS
    Microcirculation; 2010 May; 17(4):281-96. PubMed ID: 20536741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.
    Gordon K; Schulte D; Brice G; Simpson MA; Roukens MG; van Impel A; Connell F; Kalidas K; Jeffery S; Mortimer PS; Mansour S; Schulte-Merker S; Ostergaard P
    Circ Res; 2013 Mar; 112(6):956-60. PubMed ID: 23410910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel VEGFR3 mutation causes Milroy disease.
    Butler MG; Dagenais SL; Rockson SG; Glover TW
    Am J Med Genet A; 2007 Jun; 143A(11):1212-7. PubMed ID: 17458866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update.
    Gordon K; Spiden SL; Connell FC; Brice G; Cottrell S; Short J; Taylor R; Jeffery S; Mortimer PS; Mansour S; Ostergaard P
    Hum Mutat; 2013 Jan; 34(1):23-31. PubMed ID: 23074044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGFR3 is required for button junction formation in lymphatic vessels.
    Jannaway M; Iyer D; Mastrogiacomo DM; Li K; Sung DC; Yang Y; Kahn ML; Scallan JP
    Cell Rep; 2023 Jul; 42(7):112777. PubMed ID: 37454290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.
    Ghalamkarpour A; Morlot S; Raas-Rothschild A; Utkus A; Mulliken JB; Boon LM; Vikkula M
    Clin Genet; 2006 Oct; 70(4):330-5. PubMed ID: 16965327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the conserved sequence of vascular endothelial growth factor receptor 3 leads to primary lymphoedema.
    Dai T; Li B; He B; Yan L; Gu L; Liu X; Qi J; Li P; Zhou X
    J Int Med Res; 2018 Aug; 46(8):3162-3171. PubMed ID: 29896974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic System in Cardiovascular Medicine.
    Aspelund A; Robciuc MR; Karaman S; Makinen T; Alitalo K
    Circ Res; 2016 Feb; 118(3):515-30. PubMed ID: 26846644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel FLT4 mutation identified in a patient with Milroy disease.
    DiGiovanni RM; Erickson RP; Ohlson EC; Bernas M; Witte MH
    Lymphology; 2014 Mar; 47(1):44-7. PubMed ID: 25109169
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Liu N; Gao M
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function.
    Liu X; Pasula S; Song H; Tessneer KL; Dong Y; Hahn S; Yago T; Brophy ML; Chang B; Cai X; Wu H; McManus J; Ichise H; Georgescu C; Wren JD; Griffin C; Xia L; Srinivasan RS; Chen H
    Sci Signal; 2014 Oct; 7(347):ra97. PubMed ID: 25314967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
    J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Of mice and men; the translational physiology of a genetic form of lymphoedema.
    Mortimer PS; Levick JR
    J Physiol; 2006 Jul; 574(Pt 2):331. PubMed ID: 16728443
    [No Abstract]   [Full Text] [Related]  

  • 19. [Identification of VEGFR3 gene mutation in a Chinese family with autosomal dominant primary congenital lymphoedema].
    Sheng JQ; Zeng F; Li C; Liu JY; Wang Q; Liu MG
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):371-5. PubMed ID: 20677139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Milroy case with FLT4/VEGFR3 mutation and an unusual skin biopsy.
    Liu NF; Yu ZY; Lou Y; Sun D
    Br J Dermatol; 2019 Jan; 180(1):223-224. PubMed ID: 30169892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.